U.S. Markets closed

Who Owns CTI BioPharma Corp (NASDAQ:CTIC)?

Liliana Gabriel

I am going to take a deep dive into CTI BioPharma Corp’s (NASDAQ:CTIC) most recent ownership structure, not a frequent subject of discussion among individual investors. The impact of a company’s ownership structure affects both its short- and long-term performance. Differences in ownership structure of companies can have a profound effect on how management’s incentives are aligned with shareholder returns, which is why we’ll take a moment to analyse CTIC’s shareholder registry. All data provided is as of the most recent financial year end.

Check out our latest analysis for CTI BioPharma

NasdaqCM:CTIC Ownership_summary Jan 29th 18

Institutional Ownership

With an institutional ownership of 16.23%, CTIC can face volatile stock price movements if institutions execute block trades on the open market, more so, when there are relatively small amounts of shares available on the market to trade These moves, at least in the short-term, are generally observed in an institutional ownership mix comprising of active stock pickers, in particular levered hedge funds, which can cause large price swings. With hedge funds holding a 25.00% stake in the company, its share price can experience heightened volatility. But I also examine other ownership types and their potential impact on CTIC’s investment case.

Insider Ownership

I find insiders are another important group of stakeholders, who are directly involved in making key decisions related to the use of capital. In essence, insider ownership is more about the alignment of shareholders’ interests with the management. Although individuals in CTIC hold only a 1.02% stake, it’s a good sign for shareholders as the company’s executives and directors have their incentives directly linked to the company’s performance. In addition to this, it may be interesting to look at insider buying and selling activities. Keep in mind that buying may be sign of upbeat future expectations, but selling doesn’t necessarily mean the opposite as the insiders might just be doing it out of their personal financial needs.

NasdaqCM:CTIC Insider_trading Jan 29th 18

General Public Ownership

A substantial ownership of 40.59% in CTIC is held by the general public. With this size of ownership, retail investors can collectively play a role in major company policies that affect shareholders returns, including executive remuneration and the appointment of directors. They can also exercise the power to decline an acquisition or merger that may not improve profitability.

Private Equity Ownership

With a stake of 11.62%, private equity firms form another important class of owners in CTIC. With a stake of 11.62%, they can influence CTIC’s key policy decisions. This is an encouraging sign for investors as these investors tend to be active strategist in companies, focusing on increasing operational and capital efficiency for the firm.

Public Company Ownership

Potential investors in CTIC should also look at another important group of investors: other public companies, with a stake of 5.54%, who are primarily invested because of strategic and capital gain interests. With this size of ownership in CTIC, this ownership class can affect the company’s business strategy. As a result, potential investors should further explore the company’s business relations with these companies and find out if they can affect shareholder returns in the long-term.

What this means for you:

I suggest investors seek some degree of margin of safety due to high institutional ownership in CTIC, in particular due to the strong presence of active hedge fund investors. This will allow an investor to reduce the impact of non-fundamental factors, such as volatile block trading impact on their portfolio value. However, ownership structure should not be the only determining factor when you’re building an investment thesis for CTIC. Instead, you should be evaluating company-specific factors such as the intrinsic valuation, which is a key driver of CTI BioPharma’s share price. I urge you to complete your research by taking a look at the following:

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.